Eisbach Bio Receives EUR 8 Million Government Grant to Progress COVID-19 Antiviral Through Phase I/II Clinical Development
July 07, 2021 04:00 ET | AKAMPION
MUNICH, Germany, July 7, 2021 – Eisbach Bio, a biotechnology company targeting the molecular machines that drive human disease, today announced additional financial support from the German Ministry...
Adept Neuro Reaches Key Milestone in the Development of Novel Intracerebral Stereoelectroencephalography (SEEG) Electrodes
July 06, 2021 04:00 ET | AKAMPION
Second investment tranche provided by DIXI medicalPreparation of regulatory certifications and market launch Adept Neuro SA (Lausanne, Switzerland), a joint venture of DIXI Medical (Le Locle,...
Aleva Neurotherapeutics Recruits First Patient into its PMCF Study with its directSTIM™ Directional Deep Brain Stimulation System
June 17, 2021 03:00 ET | AKAMPION
- First system implanted at University Hospital of Dresden / Prof. Sobottka - Post-market clinical follow-up and revenue-generating study in the EU - Targeting US FDA IDE approval in Q4, 2021 ...
Science Translational Medicine Publication: Innovative Molecules´ Drug Candidate Affects Recurrent Herpes Simplex Virus Infections
June 16, 2021 14:00 ET | AKAMPION
- IM-250 reduces viral load, viral shedding and recurrence rate - Potential treatment for persistent, neurotrophic herpes simplex Munich, Germany, June 16, 2021 - Innovative Molecules GmbH, a drug...
Innovative Molecules raises €20 million Series A equity financing round
June 07, 2021 04:00 ET | AKAMPION
- Proceeds dedicated to advance Herpes simplex treatment IM-250 to Phase II - IM-250 demonstrates unprecedented impact on viral reservoir in preclinical studies Munich, Germany, June 7, 2021 -...
MerLion Pharmaceuticals Completes Growth Financing Round
May 18, 2021 03:30 ET | AKAMPION
- Proceeds will be used to facilitate MerLion`s production and market launch of XtoroTM Berlin, (18/05/2021) - MerLion Pharmaceuticals GmbH (MerLion), a biopharmaceutical company focused on research...
ImmunOs Therapeutics AG Receives Public Funding from Eurostars and Innosuisse for a Novel Therapeutic Antibody to Treat Inflammatory Rheumatic Diseases
April 12, 2021 03:45 ET | AKAMPION
- Company forms international consortium with ProteoGenix SAS and Amsterdam UMC Schlieren (Zurich Area), Switzerland – April 12, 2021 – ImmunOs Therapeutics AG, a Swiss bio-technology company...
T-knife Therapeutics Announces the Appointment of Donald Wuchterl as Senior Vice President and Chief Manufacturing Officer
April 07, 2021 06:00 ET | AKAMPION
San Francisco, CA / Berlin, Germany – April 7, 2021 — T-knife Therapeutics, Inc., a next-generation T-cell receptor company developing innovative therapeutics for the benefit of solid tumor patients...
SEQ-IT vermeldet Durchbruch in der schnellen Variantendiagnostik von SARS-CoV-2
February 22, 2021 04:00 ET | AKAMPION
Kaiserslautern, Deutschland, 22. Februar 2021 – SEQ-IT, ein führender Anbieter von molekularen Dienstleistungen, gibt die Entwicklung eines neuartigen Massenspektrometrie-basierten Tests für den...
SEQ-IT reports breakthrough in the rapid variant diagnosis of SARS-CoV-2
February 22, 2021 04:00 ET | AKAMPION
Kaiserslautern, Germany, February 22, 2021 – SEQ-IT, a leading molecular services provider, today announced they completed a novel mass spectrometry based rapid test for the detection of 20 of the...